공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

메타돈염산염 시장 규모 : 처방, 용도, 투여 경로, 유통채널, 지역별 - 점유율, 전망, 기회 분석(2020-2027년)

Methadone Hydrochloride Market, by Formulation, by Application, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

리서치사 Coherent Market Insights
발행일 2020년 12월 상품 코드 980027
페이지 정보 영문
가격
US $ 4,500 ₩ 5,195,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,081,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 11,545,000 PPT Turned PDF (Enterprise User License)


메타돈염산염 시장 규모 : 처방, 용도, 투여 경로, 유통채널, 지역별 - 점유율, 전망, 기회 분석(2020-2027년) Methadone Hydrochloride Market, by Formulation, by Application, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
발행일 : 2020년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 메타돈염산염 시장에서의 지위를 강화하기 위해서 주요 기업은 합병과 인수에 초점을 맞추고 있습니다. 2016년 5월, Hikma Pharmaceuticals PLC는 제약 기업인 RoxaneLaboratories, Inc를 인수했습니다. 이 인수에 의해서 Roxane Laboratories, Inc로부터 메타돈염산염을 얻고, 아편 작용제 제품 포트폴리오를 확대했습니다.

세계의 메타돈염산염(Methadone Hydrochloride) 시장에 대해 조사했으며, 시장 규모와 점유율, 기회와 동향, 성장 촉진요인 및 억제요인, 제형·용도·투여 경로·유통채널·지역별 시장 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 조사 목적과 전제조건

제2장 시장 전망

  • 보고서 개요
  • 시장의 정의와 범위
  • 개요
  • 시장 현황 : 제형별
  • 시장 현황 : 용도별
  • 시장 현황 : 투여 경로별
  • 시장 현황 : 유통채널별
  • 시장 현황 : 지역별
  • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

  • 성장요인과 억제요인
  • 시장 기회
  • 영향 분석
  • 최근의 제품 발매와 승인
  • 파이프라인 분석
  • 브랜드 분석
  • 규제 시나리오
  • PEST 분석
  • 역학
  • 환급 시나리오
  • 취득
  • 시장 동향

제4장 COVID-19 팬데믹의 영향

  • 경제적 영향
  • 연구개발
  • 정부 분석

제5장 시장 분석 : 제형별(2016-2027년)

  • 서론
  • 시장 점유율 분석(2020년&2027년)
  • 전년대비 성장 분석(2017-2027년)
  • 부문 동향
    • 정제
    • 액체

제6장 시장 분석 : 용도별(2016-2027년)

  • 서론
  • 시장 점유율 분석(2020년&2027년)
  • 전년대비 성장 분석(2017-2027년)
  • 부문 동향
    • 오피에이트 금단증상
    • 만성 통증

제7장 시장 분석 : 투여 경로별(2016-2027년)

  • 서론
  • 시장 점유율 분석(2020년&2027년)
  • 전년대비 성장 분석(2017-2027년)
  • 부문 동향
    • 경구
    • 정맥주사

제8장 시장 분석 : 유통채널별(2016-2027년)

  • 서론
  • 시장 점유율 분석(2020년&2027년)
  • 전년대비 성장 분석(2017-2027년)
  • 부문 동향
    • 병원 약국
    • 소매 약국
    • 온라인 약국

제9장 시장 분석 : 지역별(2016-2027년)

  • 서론
  • 시장 점유율 분석(2020년&2027년)
  • 전년대비 성장 분석(2017-2027년)
  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동
  • 아프리카

제10장 경쟁 구도

  • 기업 개요
    • Eli Lilly and Company
    • Sanofi SA
    • Hikma Pharmaceuticals PLC
    • Mallinckrodt Pharmaceuticals
    • Siegfried Holding AG
    • Johnson Matthey
    • Tianjin Central Pharmaceutical Co., Ltd
    • Temad Co
    • Embio LTD
    • Harman Finochem Ltd
    • Rusan Pharma Ltd
LSH 21.01.14

Title:
Methadone Hydrochloride Market, by Formulation (Tablet, Solution, and Others), by Application (Opiate Withdrawal, Chronic Pain, and Others), by Route of Administration (Oral and Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Methadone, a synthetic narcotic analgesic is part of a category called opioids. This opioid has pharmacologic actions qualitatively similar to morphine. Methadone is generally used as a pain reliever and as a part of drug addiction detoxification and maintenance therapy. Pain can be of various types such as due to surgery, strain, and others. A person experiencing severe and chronic pain is given small doses of methadone, which encounters the pain by changing the way the brain and nervous system respond to pain. Opiate dependence is a major public health problem.

Market Dynamics

Key players are focusing on mergers and acquisitions to strengthen their position in the global methadone hydrochloride market. For instance, in May 2016, Hikma Pharmaceuticals PLC acquired Roxane Laboratories, Inc., a pharmaceutical company. Through this acquisition, the company expanded its product portfolio of opiate agonist by acquiring methadone hydrochloride from Roxane Laboratories, Inc

Key features of the study:

  • This report studies the current scenario as well as the future market potential of methadone hydrochloride across the globe. The market for methadone hydrochloride has been segmented on the basis of formulation, application, route of administration, distribution channel, and region.
  • This report provides in-depth analysis of the global methadone hydrochloride market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2020-2027)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, regional outlook, and competitive strategies adopted by the leading players.
  • It profiles leading players in the global methadone hydrochloride market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future market expansion and marketing tactics
  • Key companies covered as a part of this study are Eli Lilly and Company, Sanofi S.A, Hikma Pharmaceuticals PLC, Mallinckrodt Pharmaceuticals, Siegfried Holding AG, Johnson Matthey, Tianjin Central Pharmaceutical Co., Ltd, Temad Co, Embio LTD, Harman Finochem Ltd, and Rusan Pharma Ltd.
  • The global methadone hydrochloride market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision-making through various strategy matrices used in analyzing the global methadone hydrochloride market

Detailed Segmentation:

  • Global Methadone Hydrochloride Market, By Formulation :
    • Tablet
    • Solution
    • Others
  • Global Methadone Hydrochloride Market, By Application:
    • Opiate Withdrawal
    • Chronic Pain
    • Others
  • Global Methadone Hydrochloride Market, By Route of Administration :
    • Oral
    • Intravenous
  • Global Methadone Hydrochloride Market, By Distribution Channel :
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Methadone Hydrochloride Market, By Region:
    • North America
      • By Formulation :
      • Tablet
      • Solution
      • Others
      • By Application:
      • Opiate Withdrawal
      • Chronic Pain
      • Others
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Formulation :
      • Tablet
      • Solution
      • Others
      • By Application:
      • Opiate Withdrawal
      • Chronic Pain
      • Others
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Formulation :
      • Tablet
      • Solution
      • Others
      • By Application:
      • Opiate Withdrawal
      • Chronic Pain
      • Others
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Formulation :
      • Tablet
      • Solution
      • Others
      • By Application:
      • Opiate Withdrawal
      • Chronic Pain
      • Others
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Formulation :
      • Tablet
      • Solution
      • Others
      • By Application:
      • Opiate Withdrawal
      • Chronic Pain
      • Others
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Formulation :
      • Tablet
      • Solution
      • Others
      • By Application:
      • Opiate Withdrawal
      • Chronic Pain
      • Others
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Eli Lilly and Company *
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Sanofi S.A
    • Hikma Pharmaceuticals PLC
    • Mallinckrodt Pharmaceuticals
    • Siegfried Holding AG
    • Johnson Matthey
    • Tianjin Central Pharmaceutical Co., Ltd
    • Temad Co
    • Embio LTD
    • Harman Finochem Ltd
    • Rusan Pharma Ltd

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snapshot, By Formulation
  • Market Snapshot, By Application
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Drivers and Restraints
  • Opportunities
  • Impact Analysis
  • Recent Product launches and Approvals
  • Pipeline Analysis
  • Brand Analysis
  • Regulatory Scenario
  • PEST Analysis
  • Epidemiology
  • Reimbursement Scenario
  • Acquisition
  • Market Trend

4. Global Methadone Hydrochloride Market - Impact of Coronavirus (COVID-19) Pandemic

  • Economic Impact
  • Research and Development
  • Government Analysis

5. Global Methadone Hydrochloride Market, By Formulation, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Tablet
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)

6. Global Methadone Hydrochloride Market, By Application, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Opiate Withdrawal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Chronic Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)

7. Global Methadone Hydrochloride Market, By Route of Administration, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)

8. Global Methadone Hydrochloride Market, By Distribution Channel, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)

9. Global Methadone Hydrochloride Market, By Region, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, By Country, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, For Countries, 2017-2027
  • North America
  • Introduction
  • Market Size and Forecast, By Formulation, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Application 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, By Formulation, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Application 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, By Formulation, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Application 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, By Formulation, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Application 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, By Formulation, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Application 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, By Formulation, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Application 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2016-2027 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

10. Competitive Landscape

  • Company Profiles
    • Eli Lilly and Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi S.A
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Hikma Pharmaceuticals PLC
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Mallinckrodt Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Siegfried Holding AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson Matthey
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Tianjin Central Pharmaceutical Co., Ltd
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Temad Co
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Embio LTD
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Harman Finochem Ltd
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Rusan Pharma Ltd
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
Back to Top
전화 문의
F A Q